Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT03117335 · COMPLETED
Trial details
- NCT number
- NCT03117335
- Sponsor
- Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-10
- Primary completion
- 2016-11-14
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.